Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2840748 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-NFkB cRel (AA 586-619), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is purified through a protein G column, followed by dialysis against PBS.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 586-619, C-Term
- Antibody clone number
- RB8325
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence.
Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, Pourtier A, Vandenbunder B, Abbadie C
Cancer research 2004 Jan 15;64(2):472-81
Cancer research 2004 Jan 15;64(2):472-81
Discreet mutations from c-Rel to v-Rel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity.
Phelps CB, Ghosh G
Oncogene 2004 Feb 12;23(6):1229-38
Oncogene 2004 Feb 12;23(6):1229-38
Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
Jain A, Ma CA, Lopez-Granados E, Means G, Brady W, Orange JS, Liu S, Holland S, Derry JM
The Journal of clinical investigation 2004 Dec;114(11):1593-602
The Journal of clinical investigation 2004 Dec;114(11):1593-602
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB